BioNTech SE (BNTX)
101.98
+0.37
(+0.36%)
USD |
NASDAQ |
Sep 01, 16:00
102.00
+0.02
(+0.02%)
After-Hours: 20:00
BioNTech Cash from Operations (Annual) : 514.63M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 514.63M |
| December 31, 2024 | 224.67M |
| December 31, 2023 | 5.807B |
| December 31, 2022 | 14.27B |
| December 31, 2021 | 1.052B |
| Date | Value |
|---|---|
| December 31, 2020 | -15.36M |
| December 31, 2019 | -222.21M |
| December 31, 2018 | -68.64M |
| December 31, 2017 | -59.29M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Moderna, Inc. | -1.873B |
| Biodexa Pharmaceuticals Plc | -7.268M |
| NuCana Plc | -9.377M |
| Mereo BioPharma Group Plc | -31.04M |
| MediGene AG | -- |